109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
MODULATION OF AXON DEGENERATION
#6902Modulation of ciliogenesis
#6903BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY
#6904Compositions and methods for modifying a target nucleic acid
#6905Methods and compositions for integration defective lentiviral vectors
#6906Toxic RNAi active seed sequences for killing cancer cells
#6907Methods and Compositions for Selecting siRNA of Improved Functionality
#6908Chimeric double-stranded nucleic acid
#6909AGE-RELATED MACULAR DEGENERATION TREATMENT
#6910LANOSTEROL 14-ALPHA DEMETHYLASE (CYP51) NUCLEIC ACID MOLECULES THAT CONTROL PATHOGENS
#6911Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#6912COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER FIBROSIS
#6913INTRATHECAL DELIVERY OF NUCLEIC ACID SEQUENCES ENCODING ABCD1 FOR TREATMENT OF ADRENOMYELONEUROPATHY
#6914RNA interactome of polycomb repressive complex 1 (PRC1)
#6915Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia
#6916POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES
#6917NMDAR antagonists for the treatment of diseases associated with angiogenesis
#6918Method for treating schizophrenia
#6919Compounds and methods for modulating C90RF72
#6920DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY
#6921Mantle phenotype detection in palm
#6922Ovary Tumor Markers And Methods Of Use Thereof
#6923Methods and compositions related to T-cell activity
#6924Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#6925Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#6926Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#6927Identification and use of target genes for control of plant parasitic nematodes
#6928ALGAL PROMOTERS
#6929Methods of treatment using antisense oligomers and conjugates targeting PCSK9
#6930Manufacture of antisense oligomers and conjugates targeting PCSK9
#6931RIG-I ligands and methods for producing them
#6932COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE
#6933METHODS AND COMPOSITIONS FOR INCREASING SMN EXPRESSION
#6934MODULATION OF MICRORNA 184 TO TREAT PATHOLOGICAL LYMPHANGIOGENESIS
#6935Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#6936Engineered nucleic-acid targeting nucleic acids
#6937Agents and methods to elicit anti-tumor immune response
#6938Leg1 Protein, Leg1 Gene, and Uses and Drugs thereof
#6939Method of treating delayed healing of a wound associated with diabetes
#6940Methods and compositions relating to proteasome inhibitor resistance
#6941CRISPR effector system based diagnostics for malaria detection
#6942Methods and compositions for the activation of gamma-delta T-cells
#6943Nucleic acid molecules containing spacers and methods of use thereof
#6944PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS
#6945Transgenic plant of the species with resistance to
#6946CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#6947PARENTAL RNAI SUPPRESSION OF HUNCHBACK GENE TO CONTROL HEMIPTERAN PESTS
#6948Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#6949Antisense oligonucleotides for the treatment of leber congenital amaurosis
#6950MicroRNA Compounds and Methods for Modulating MIR-21 Activity
#6951Targeting MicroRNAs for the Treatment of Fibrosis
#6952SARNA COMPOSITIONS AND METHODS OF USE
#6953Method and System for Monitoring Nutritional Uptake as a Function of Hydrogen Gas Levels
#6954NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS
#6955POLYNUCLEOTIDES HAVING BIOREVERSIBLE GROUPS
#6956METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#6957METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#6958Methods for Treatment of Alport Syndrome
#6959COMPOSITIONS AND METHODS FOR MODULATING SMN GENE FAMILY EXPRESSION
#6960Peptide oligonucleotide conjugates
#6961Non-coding RNAs linked to immortality and associated methods and compositions
#6962Chimeric decoy
#6963Modified AAV constructs and uses thereof
#6964Compounds for targeting drug delivery and enhancing siRNA activity
#6965Method of treating cancer with compositions comprising IL-31
#6966Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish
#6967Methods for diagnosing Huntington's disease
#6968Treatment targeting oncology and neurodegeneration
#6969SELECTIVE REDUCTION OF ALLELIC VARIANTS
#6970Oligonucleotide inhibitor of DNA polymerases
#6971Interfering RNA molecules
#6972Blood Brain Barrier Opening Agents and Uses Thereof
#6973COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
#6974ETS factors regulate neural stem cell depletion and gliogenesis in Ras pathway glioma
#6975INHIBITORS OF MICRORNAs miR-155, miR-103, miR-105 and miR-107 THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF
#6976USE OF THERAPEUTIC AGENTS
#6977Method for altering the functional state of mRNA allowing its selective and specific recognition
#6978Micelle composition for nucleic acid delivery using temperature-sensitive polymer and method for producing same
#6979METHODS OF PRESERVING THE BIOLOGICAL ACTIVITY OF RIBONUCLEIC ACIDS
#6980Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos
#6981Treatment and diagnosis of immune disorders
#6982Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#6983PRE-MRNA PROCESSING FACTOR 19 (PRP19) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#6984Therapeutic agent for sarcopenia and metabolic diseases
#6985ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
#6986Plant-mediated silencing of a fatty acid and retinoid binding protein in
#6987Bioactive renal cells
#6988Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
#6989Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
#6990Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
#6991Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
#6992FALZ for use as a target for therapies to treat cancer
#6993Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier
#6994METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#6995PROTECTED DNA TEMPLATES FOR GENE MODIFICATION AND INCREASED HOMOLOGOUS RECOMBINATION IN CELLS AND METHODS OF USE
#6996ACC OX promoter identified by microarray analysis
#6997A CRISPR/Cas9 SYSTEM FOR HIGH EFFICIENT SITE-DIRECTED ALTERING OF PLANT GENOMES
#6998Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
#6999Induced exon inclusion in spinal muscle atrophy
#7000Compositions and methods for modulating apolipoprotein (a) expression
#7001Compositions and methods for modulating apolipoprotein C-III expression
#7002Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
#7003Methods and compositions for the production of siRNAs
#7004MODULATION OF TRANSTHYRETIN EXPRESSION
#7005RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
#7006Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
#7007MODULATION OF TRANSTHYRETIN EXPRESSION
#7008Compositions and their uses directed to huntingtin
#7009Oligonucleotide-based inhibitors comprising locked nucleic acid motif
#7010Modulation of SMN expression
#7011Compounds and methods for modulation of DUX4
#7012Short non-coding protein regulatory RNAs (sprRNAs) and methods of use
#7013Genome editing enhancement
#7014Methods and compositions for sequence specific antimicrobials
#7015Methods and compositions for generating CRISPR/Cas guide RNAs
#7016Methods and compositions for modifying a single stranded target nucleic acid
#7017Methods and compositions related to increased influenza virus production
#7018Combination therapy for treatment of disease
#7019Materials and methods for treatment of hemoglobinopathies
#7020MODULATORS OF KRAS EXPRESSION
#7021Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
#7022Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44
#7023EFFICIENT AND SAFE TRANSPOSON INTEGRATION SYSTEM AND USE THEREOF
#7024P0 gene silencing constructs and use
#7025RIBOSOMAL NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#7026AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#7027Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage (3dT)
#7028METHODS AND COMPOSITIONS COMPRISING APSE KNOTS
#7029NUCLEIC ACID MOLECULES WITH ENHANCED ACTIVITY
#7030Antisense nucleic acids
#7031RAAV-BASED COMPOSITIONS AND METHODS
#7032METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES
#7033Polypeptides, nucleic acids and uses thereof
#7034Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing progression of lung fibrosis after a lung injury
#7035Motor neuron-specific expression vectors
#7036Pharmaceutical composition for treating or preventing obesity
#7037Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin
#7038SARNA COMPOSITIONS AND METHODS OF USE
#7039METHODS AND COMPOSITIONS FOR THE TREATMENT OF A METABOLIC DISORDER
#7040Modified iRNA agents
#7041Compounds for inducing anti-tumor immunity and methods thereof
#7042Compositions and methods for modulating Ataxin 3 expression
#7043METHOD OF IDENTIFYING GENOME-WIDE OFF-TARGET SITES OF BASE EDITORS BY DETECTING SINGLE STRAND BREAKS IN GENOMIC DNA
#7044Rapid characterization of Cas endonuclease systems, PAM sequences and guide RNA elements
#7045Compositions and methods for modulating FMR1 expression
#7046Hydrogels for delivery of therapeutic compounds
#7047Methods and compositions for modulating apolipoprotein (a) expression
#7048Methods for therapeutic administration of messenger ribonucleic acid drugs
#7049Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
#7050MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#7051METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7052METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7053METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7054Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#7055METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7056Engineered nucleic acid-targeting nucleic acids
#7057COPI COATOMER BETA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS
#7058Increasing plant oil content by altering a negative regulator of acetyl-coa carboxylase
#7059Antisense oligonucleotide compositions
#7060Targeting microRNAs for metabolic disorders
#7061Oligonucleotide conjugates
#7062Compositions and Methods for Inducing Senescence in Cancer Cells
#7063Use of trinucleotide repeat RNAs to treat cancer
#7064Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#7065Antisense nucleic acid for treating amyotrophy
#7066Amino acid-modified nucleic acid and utilization thereof
#7067Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#7068Androgenetic haploid embryonic stem cell (AG-HAESC), and preparation method and use thereof
#7069METHODS AND COMPOSITIONS FOR MODULATING MONOCYTE POPULATIONS AND RELATED USES THEREOF
#7070COLON DISEASE TARGETS AND USES THEREOF
#7071PYRAZOLOTRIAZOLYL NUCLEOSIDE ANALOGUES AND OLIGONUCLEOTIDES COMPRISING THEM
#7072COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR
#7073MODIFIED POLY (BETA-AMINO ESTER)S FOR DRUG DELIVERY
#7074Pharmaceutical composition containing anionic drug, and preparation method therefor
#7075MIR-19 MODULATORS AND USES THEREOF
#7076Methods for detection of RNase activity
#7077Methods and compositions for determining pH
#7078METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7079METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7080Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#7081COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#7082RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#7083PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS
#7084Polycomb-associated non-coding RNAs
#7085Methods and compositions to treat liver diseases and conditions
#7086Methods and compositions for altering function and structure of chromatin loops and/or domains
#7087Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa
#7088COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
#7089MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPODYSTROPHY POPULATIONS
#7090Humanized model of kidney and liver disorders
#7091METHOD AND COMPOSITIONS FOR REMOVING DUPLICATED COPY NUMBER VARIAIONS (CNVS) FOR GENETIC DISORDERS AND RELATED USES
#7092THERAPEUTIC CELL INTERNALIZING CONJUGATES
#7093Block copolymers
#7094Compounds and methods for trans-membrane delivery of molecules
#7095Methods and compositions for eliciting an immune response against hepatitis B virus
#7096THE SCANO-miR PLATFORM IDENTIFIES A DISTINCT CIRCULATING MICRORNA SIGNATURE FOR THE DIAGNOSIS OF DISEASE
#7097Structuring fats and methods of producing structuring fats
#7098METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7099GENE EDITING OF PCSK9
#7100UNA oligomers for therapeutics with prolonged stability
#7101MiR-92 inhibitors and uses thereof
#7102ANTISENSE DESIGN
#7103ANTISENSE DESIGN
#7104Methods and compositions for modlating apolipoprotein (A) expression
#7105ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
#7106METHODS OF SCREENING FOR RIBOSWITCHES AND ATTENUATORS
#7107Splice-region antisense composition and method
#7108Compositions and Methods of Nucleic Acid-Targeting Nucleic Acids
#7109EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS
#7110ANTISENSE COMPOSITIONS TARGETING ERWINIA SPECIES AND METHODS OF USING THE SAME
#7111Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
#7112METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7113METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7114METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#7115Method for expression of small RNA molecules within a cell
#7116Compositions and methods for inhibiting gene expression of Hif2alpha
#7117Method of treating pain with an antibody against netrin-4, UNC5B or neogenin
#7118Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#7119Brush polymer-assisted compaction of oligonucleotides
#7120METHODS FOR TREATING TUMORS
#7121METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#7122Notch inhibition in the treatment and prevention of nonalcoholic fatty liver disease
#7123Bicistronic AAV vector for RNA interference in ALS
#7124NUCLEIC ACID COMPLEX HAVING AT LEAST ONE BULGE STRUCTURE
#7125ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS
#7126COPI COATOMER GAMMA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS
#7127Methods and Materials for Producing Fruit of Altered Size
#7128Methods and hybrids for targeted nucleic acid editing in plants using CRISPR/Cas systems
#7129Interfering RNA molecules
#7130Multimeric oligonucleotides having decreased kidney clearance
#7131ANTISENSE FINGERLOOP RNAS AND USES THEREOF
#7132Compositions and methods for modulating MECP2 expression
#7133Structurally-enhanced miRNA inhibitor S-TuD
#7134NUCLEIC ACID COMPLEX
#7135THERAPEUTIC OLIGONUCLEOTIDES
#7136Functionally-modified oligonucleotides and subunits thereof
#7137Precursor miRNA and applications in tumor therapy thereof
#7138Molecular sensor selection
#7139Compositions and methods for treating leukemia
#7140Agents for use in the treatment of glioma
#7141Treatments of oxidative stress conditions
#7142Nuclease with enhanced efficiency of genome editing
#7143Nucleic acid molecules that control pathogens
#7144Reducing levels of nicotinic alkaloids in plants
#7145Diplospory gene
#7146Engineered shell proteins for microcompartment shell electron transfer and catalysis
#7147Antisense oligomers targeting PCSK9
#7148MicroRNA-328 anti-sense composition and therapeutic use
#7149Oligonucleotide compositions and methods thereof
#7150OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#7151Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy
#7152Biological control of coleopteran pests
#7153HSD17B13 variants and uses thereof
#7154Modified siRNA and pharmaceutical composition
#7155MODULATION OF SRPX2-MEDIATED ANGIOGENESIS
#7156microRNAS FOR THE TREATMENT OF HEART DISEASES
#7157Methods and compositions for selecting siRNA of improved functionality
#7158METHOD FOR INDIVIDUALIZED CANCER THERAPY
#7159Base sequence for protein expression and method for producing protein using same
#7160Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#7161TREATMENT OF LIPID TRANSPORT AND METABOLISM GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A LIPID TRANSPORT AND METABOLISM GENE
#7162Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#7163TOOLS AND METHODS USING MIRNA 182, 96 AND/OR 183 FOR TREATING PATHOLOGIES
#7164Multi-targeted single entity conjugates
#7165ANTISENSE OLIGONUCLEOTIDE INHIBITING ß2GPI EXPRESSION
#7166Inhibition of microRNA-134 for the treatment of seizure-related disorders and neurologic injuries
#7167Method of synthesis of an ionizable cationic lipid
#7168Cationic lipids for therapeutic agent delivery formulations
#7169OLIGONUCLEOTIDE DERIVATIVE
#7170Targeted integration into the PPP1R12C locus
#7171Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof
#7172Fidgetin-like 2 as a target to enhance wound healing
#7173Methods and compositions for selecting siRNA of improved functionality
#7174Compounds for inducing anti-tumor immunity and methods thereof
#7175Albumin production and cell proliferation
#7176Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#7177COMPOUNDS AND METHODS FOR MODULATING TARGET NUCLEAR AND SUB-NUCLEAR NUCLEIC ACID MOLECULES IN CELLS AND ANIMALS
#7178Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
#7179Micromirs
#7180NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT
#7181Engineered nucleic-acid targeting nucleic acids
#7182ANTI-ANGIOGENIC VEGF-AX ISOFORM
#7183Materials and methods for treatment of human genetic diseases including hemoglobinopathies
#7184Control of coleopteran pests using RNA molecules
#7185PEST CONTROL SYSTEM
#7186Compositions and methods for inhibiting gene expression of LPA
#7187Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#7188Methods for treating apolipoprotein E4-associated disorders
#7189Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
#7190Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
#7191Transgenic microalgae and use thereof as a feed for delivery of interfering RNA molecules
#7192Therapeutic agent for a lung disease and/or method for screening for the same
#7193DISCONTINUOUS OLIGONUCLEOTIDE LIGANDS
#7194Pharmaceutical Composition
#7195CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
#7196Nanoconjugates able to cross the blood-brain barrier
#7197ß2GPI GENE EXPRESSION-SUPPRESSING NUCLEIC ACID CONJUGATE
#7198Micro-RNA for the treatment of malignant solid tumors and metastasis
#7199Nanocarriers and their processing for diagnostics and therapeutics
#7200Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery